抄録
Because WT1 is expressed in leukemia cells, the development of cancer immunotherapy targeting WT1 has been an attractive translational research topic. However, concern of this therapy still remains, since WT1 is abundantly expressed in renal glomerular podocytes. In the present study, we clearly showed that WT1-specific cytotoxic T lymphocytes (CTLs) certainly exerted cytotoxicity against podocytes in vitro; however, they did not damage podocytes in vivo. This might be due to the anatomical localization of podocytes, being structurally separated from circulating CTLs in glomerular capillaries by an exceptionally thick basement membrane.
| 本文言語 | 英語 |
|---|---|
| 論文番号 | 3 |
| ジャーナル | Journal of Hematology and Oncology |
| 巻 | 7 |
| 号 | 1 |
| DOI | |
| 出版ステータス | 出版済み - 06-01-2014 |
| 外部発表 | はい |
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
-
SDG 3 すべての人に健康と福祉を
All Science Journal Classification (ASJC) codes
- 分子生物学
- 血液学
- 腫瘍学
- 癌研究
フィンガープリント
「Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。引用スタイル
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver